Immunis last raised $12.0M in its Early Stage VC (May 2026).
- ·The complete investor list: 12 names
- ·Watch Immunis: the Monday email on marks, rounds and moves
Immunis funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2026 | Early Stage VC | $12.0M | ▮ | ▮ |
| Jun 2024 | Early Stage VC | $20.4M | ▮ | ▮ |
Membership and data by Private Market View
Immunis valuation
Immunis's last known valuation is $75 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Immunis raised?
Immunis has raised $37 million across 2 recorded rounds since 2024. The largest was a $20.4 million early-stage round in Jun 2024; the most recent was a $12 million early-stage round in May 2026.
Immunis has filed 2 Form Ds with the SEC, most recently in Oct 2024 ($20.4 million sold to 27 investors).
How Immunis's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Immunis, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Immunis
- What is Immunis worth?
- Immunis's last known valuation is $75.0M.
- How much has Immunis raised?
- Immunis has raised $37.0M in total funding across 2 recorded rounds.
- When did Immunis last raise?
- Immunis last raised in May 2026 (Early Stage VC), raising $12.0M.